Edit |   |
---|---|
Antigenic Specificity | CD52, Human (Alemtuzumab biosimilar) |
Clone | Alemtuzumab |
Host Species | Recombinant Rabbit |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD52 Recombinant Antibody (Alemtuzumab). Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.[1] In CLL, it has been used as both a first line and second line treatment.[ |
Immunogen | n/a |
Other Names | Anti-CD52 Recombinant Antibody, Research Grade Alemtuzumab, Anti-Human CD52 Recombinant Antibody(Alemtuzumab), Campath-1H, LDP-03, Antibody Drug Analogues, Monoclonal Antibody, YR1016, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 216503-57-0 |
Catalog # | YR1016 |
Price | please inquire |
Order / More Info | CD52, Human (Alemtuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |